Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico.

Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico. Int J Clin Pharmacol Ther. 2012 Jan; 50(1):1-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.